We identified four factors that are easily recognized in daily practice and can help select patients with low life expectancy. Therefore, invasive procedures and hospitalizations for this subgroup of patients can be prevented.
Introdução: Existe divergência entre a gravidade e taxa de mortalidade nas crianças oncológicas dependendo do país ou do centro de saúde estudado, mediante isso, identificou-se a necessidade de desenvolver um estudo, com o objetivo de caracterizar esta população e identificar o motivo pelo qual o paciente é submetido ao exame para pesquisa da COVID-19 e seu desfecho clínico. Métodos: Estudo descritivo, retrospectivo realizado entre fevereiro de 2020 a fevereiro de 2022. Foram incluídos pacientes com idade inferior a 18 anos, durante o tratamento em um Cancer Center brasileiro. Resultados: Foram identificados 668 pacientes. Divididos em dois grupos: Grupo 1, 122 (18%) apresentando sintomas clínicos e Grupo 2, com 546 (82%) pacientes que foram submetidos à coleta do exame antes do procedimento cirúrgico e/ou exame de imagem. A mediana da idade entre os grupos foi de 9 e 7 anos, respectivamente. Quase a totalidade dos pacientes do Grupo 1, apresentou sintomas relacionados à COVID-19 e todos que apresentaram neutropenia febril pertenciam a este grupo. Tumores hematológicos foram prevalentes no Grupo 1, já no Grupo 2, foram identificados a mal formação venosa. Do total, 27 (4%) pacientes apresentaram resultado positivo e apenas um paciente evoluiu a óbito. Conclusão: A COVID-19 atingiu ambos os gêneros e a sua gravidade foi independente da doença de base ou idade. As medidas de proteção e prevenção ao longo do período da pandemia, permitiram que a baixa taxa de contaminação e mortalidade nos pacientes deste estudo não interrompessem o tratamento.
There is divergence between the severity and mortality rate in oncological children depending on the country or the health center studied, therefore, it was identified the need to develop a study, with the objective of characterizing this population and identifying the reason why the patient is submitted to the examination for research of COVID-19 and its clinical outcome. Methods: Descriptive, retrospective study carried out between February 2020 to February 2022. Patients younger than 18 years of age during treatment at a Brazilian Cancer Center. Results: 668 patients were identified. Divided into two groups: Group 1, 122 (18%) presenting clinical symptoms and Group 2, with 546 (82%) patients who submitted to exam collection prior to the surgical procedure and/or imaging exam. The median age between the groups was 9 and 7 years, respectively. Almost all patients in Group 1, had symptoms related to COVID-19 and all who had feverish neutropenia belonged to this group. The most prevalent underlying disease in Group 1, was hematological and in Group 2, venous malformation. Of the total, 27 (4%) patients tested positive and only one patient died. Conclusion: COVID-19 affected both genders and its severity were independent of underlying disease or age. The protection and prevention measures throughout the period of the pandemic, allowed the low rate of contamination and severity and mortality in the patients of this study not to interrupt the treatment and its follow-up.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.